An Open-Label, Multiple-Dose, Multiple-Day, Non-Randomized, Single-Arm Safety Study Of Repeat-Doses Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain.
Phase of Trial: Phase III
Latest Information Update: 20 Oct 2010
At a glance
- Drugs Diclofenac (Primary)
- Indications Postoperative pain
- Focus Adverse reactions
- Sponsors Javelin Pharmaceuticals
- 23 Jun 2009 Status changed from active, no longer recruiting to completed, as reported by Javelin in a media release.
- 01 May 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 May 2009 Planned number of patients changed from 700 to 850 as reported by ClinicalTrials.gov.